Inclusive innovation

How Biocon brought biotech to all

When Kiran Mazumdar-Shaw launched Biocon from her garage in Bangalore, she wasn’t chasing billion-dollar valuations—she was chasing access. Today, her vision of inclusive innovation has helped turn India into a global biotech powerhouse.

In India, biotechnology is a major driver of economic and technological growth. The sector, whose bioeconomy could touch US$300bn in value by 2030, plays a critical role through innovations such as vaccines, biopharmaceuticals and agricultural solutions.

However, regulatory frameworks, funding gaps and underdeveloped distribution infrastructure mean they can be woefully out of reach for many.

For Kiran Mazumdar-Shaw, founder and executive chairperson of Biocon Group, broadening access to life-saving biopharmaceuticals thus sat at the heart of her story as an “accidental entrepreneur.” A qualified brewmaster, she realised she could apply her expertise in fermentation technology to enzymes and pharmaceuticals instead of beer. This was in the 1970s, when India’s biotech sector did not exist. Ms Mazumdar-Shaw saw this as a breakthrough opportunity.

An opportunity to make a difference

Determined to pioneer biotech for India, and driven by a belief in the power of science and a desire to make a difference in society, Ms Mazumdar-Shaw went on to found Biocon, considered to be India’s first and most successful biotech startup. Under her leadership, it has grown into a multibillion-dollar global biopharma company, serving millions of patients across 120 countries. A remarkable achievement in the science-led startup space and a poignant one, considering the gender bias she faced in the brewing world decades ago.

Biocon has become a lifesaver for many in India, as well as in other countries, given its focus on developing affordable medicines for chronic conditions and enabling equitable access to patients. Starting in 2000s, the company developed a pipeline of biosimilars—affordable alternatives to pricey biologics—like the groundbreaking recombinant human insulin in 2004 and biosimilar trastuzumab in 2014. Previously, the lack of human insulin availability in India meant that patients in the country had to rely on animal insulin, a cheaper but ultimately incompatible option.

“We had to do something about it and that’s how we developed the most affordable insulin anywhere in the world.”

— Kiran Mazumdar-Shaw, founder and executive chairperson, Biocon Group

“We had to do something about it and that’s how we developed the most affordable insulin anywhere in the world,” she reflected in an interview with McKinsey. This innovative achievement, alongside her cutting-edge work on cancer treatments like CAR-T therapies, can be traced to Ms Mazumdar-Shaw’s ability to think outside the box.

“I’m a pioneer because I did what nobody else was doing, and when you’re in that frame of mind, you’re more willing to experiment, to explore and have setbacks,” she said. “I have always tried to challenge the status quo. I also have adopted the ethos of always asking myself what I can do next. That’s how I have built Biocon over the years.”

Leadership grounded in people

As a leader, Ms Mazumdar-Shaw’s philosophy is deeply rooted in building an ecosystem and connecting with people—at all levels. “I try to network with the science and technology communities in every possible way,” she said, citing her CAR-T startup, built in collaboration with leading oncologist and Pulitzer prize-winning author Siddhartha Mukherjee, who is based in the US. She also supports the government for whom she often serves as an advisor on policy matters relating to the biotech industry. Her goal, through these, is to push for regulatory reform to “unleash innovation potential".

“I make everyone a problem solver and develop that team spirit right from the beginning. That kind of culture allowed me to inspire people and build up Biocon.”

— Kiran Mazumdar-Shaw, founder and executive chairperson, Biocon Group

Her commitment to an ecosystem also extends to mentorship, working with bright minds fresh out of university to foster an innovative mindset, and generating loyalty along the way. “I make everyone a problem solver and develop that team spirit right from the beginning. That kind of culture allowed me to inspire people and build up Biocon.”

Biocon’s achievements prove that success can come from a strong belief in people, social impact and principles. And its pioneering innovations, made possible by Ms Mazumdar-Shaw’s strategic leadership style, lay the foundations and plant the seeds for India’s growing biotech sector, ready for the next trailblazer to take on.

More people behind the moves

Start of carousel.

Toshiaki Higashihara
Profile

A spin on tradition

Asian businesses are steeped in tradition, but the same qualities that once underpinned stability can impede agility.

A professional headshot of Ted Chung, the vice chairman and chief executive of Hyundai Card, smiling with his hand on his chin.
Profile

Bucking norms

Hyundai Card’s Ted Chung highlights the urgency of adapting in a more volatile global economy.

Profile

The next chapter

As Singapore transformed from fledgling nation to financial powerhouse, DBS evolved alongside it.

Profile

What dreams are made of

From modest beginnings, Uday Kotak quietly built one of India’s leading banks.

End of carousel.